RLAY - Relay Therapeutics upgraded by Barclays ahead of data readout
2024-05-10 11:13:46 ET
More on Relay Therapeutics
- Relay Therapeutics: Platform More Important Than Programs
- Relay Therapeutics: Tapping Into An Unmet Need At A High Price Tag
- Relay Therapeutics GAAP EPS of -$0.62 beats by $0.10, revenue of $10.01M beats by $9.09M
- Seeking Alpha’s Quant Rating on Relay Therapeutics
- Historical earnings data for Relay Therapeutics